APA (7th ed.) Citation

Spalinger, M. R., Hai, R., Li, J., Santos, A. N., Nordgren, T. M., Tremblay, M. L., . . . McCole, D. F. (2020, December 9). Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells bioRxiv. https://doi.org/10.1101/2020.12.09.416586

Chicago Style (17th ed.) Citation

Spalinger, Marianne R., et al. "Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells." BioRxiv 9 Dec. 2020. https://doi.org/10.1101/2020.12.09.416586.

MLA (9th ed.) Citation

Spalinger, Marianne R., et al. "Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells." BioRxiv, 9 Dec. 2020, https://doi.org/10.1101/2020.12.09.416586.